Literature DB >> 7120046

Comparison of the disposition of total and unbound sulfisoxazole after single and multiple dosing.

S Oie, J G Gambertoglio, L Fleckenstein.   

Abstract

Plasma concentrations of total and unbound sulfisoxazole were followed after single intravenous and oral doses of 1 g sulfisoxazole and during a 500-mg, four-time-a-day dosing regimen in six healthy males, using a specific high pressure liquid chromatographic assay method. Saturable plasma protein binding was observed at total concentrations above 80-100 mg/liter. The clearance of sulfisoxazole was 18.7 +/- 3.9 ml/min for total drug and 232 +/- 64 ml/min for unbound drug. Renal elimination, on the average, accounted for 49% of the clearance of sulfisoxazole. The apparent volume of distribution for total drug was 10.9 +/- 2.0 liters and 136 +/- 36 liters for unbound drug, indicating that sulfisoxazole is primarily distributed extracellularly. Accumulation of N4-acetyl-sulfisoxazole during multiple dosing did not affect the disposition of sulfisoxazole. Adjusting for variable renal clearances between oral and intravenous administration and using the unbound plasma concentrations, the bioavailability for an oral dose of sulfisoxazole was found to be 0.95 +/- 0.04.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7120046     DOI: 10.1007/bf01062333

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  17 in total

1.  Commentary: a physiological approach to hepatic drug clearance.

Authors:  G R Wilkinson; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  Kinetics of sulfisoxazole acetylation and excretion in humans.

Authors:  E NELSON; I O'REILLY
Journal:  J Pharmacol Exp Ther       Date:  1960-08       Impact factor: 4.030

3.  The choice of antimicrobial drugs.

Authors: 
Journal:  Med Lett Drugs Ther       Date:  1976-01-30       Impact factor: 1.909

4.  Pharmacokinetic profile of sulfisoxazole following intravenous, intramuscular, and oral administration to man.

Authors:  S A Kaplan; R E Weinfeld; C W Abruzzo; M Lewis
Journal:  J Pharm Sci       Date:  1972-05       Impact factor: 3.534

5.  Effect of saturable binding on the pharmacokinetics of drugs: a simulation.

Authors:  S Oie; T W Guentert; T N Tozer
Journal:  J Pharm Pharmacol       Date:  1980-07       Impact factor: 3.765

6.  "High-pressure" liquid chromatography of sulfisoxazole and N4-acetylsulfisoxazole in body fluids.

Authors:  D Jung; S Oie
Journal:  Clin Chem       Date:  1980-01       Impact factor: 8.327

7.  Protein binding of sulfonamides and displacing effects of sulfinpyrazone on the bound sulfonamides in nephrotic patients in the remissive stage.

Authors:  T Kawamura; N Yagi; K Yamahata; M Ohnishi; J Kadowaki; M Takada
Journal:  Chem Pharm Bull (Tokyo)       Date:  1980       Impact factor: 1.645

8.  Quantitative determination of the bacteriostatically active fraction of sulfonamides and the sum of their inactive metabolites in the body fluids.

Authors:  J Rieder
Journal:  Chemotherapy       Date:  1972       Impact factor: 2.544

9.  Binding of four sulphonamides to human albumin.

Authors:  R Zini; P d'Athis; A Hoareau; J P Tillement
Journal:  Eur J Clin Pharmacol       Date:  1976-06-15       Impact factor: 2.953

10.  [Physicochemical and biological studies on sulfonamides. 1. Pharmacologically interesting physicochemical characteristics of 21 sulfonamides and 6 sulfonamide metabolites].

Authors:  J RIEDER
Journal:  Arzneimittelforschung       Date:  1963-02
View more
  9 in total

Review 1.  Trends in oral drug bioavailability following bariatric surgery: examining the variable extent of impact on exposure of different drug classes.

Authors:  Adam S Darwich; Kathryn Henderson; Angela Burgin; Nicola Ward; Janet Whittam; Basil J Ammori; Darren M Ashcroft; Amin Rostami-Hodjegan
Journal:  Br J Clin Pharmacol       Date:  2012-11       Impact factor: 4.335

2.  Pharmacokinetics from a dynamical systems point of view.

Authors:  J M van Rossum; J E de Bie; G van Lingen; H W Teeuwen
Journal:  J Pharmacokinet Biopharm       Date:  1989-06

3.  Effect of saturable serum protein binding on the pharmacokinetics of unbound cefonicid in humans.

Authors:  M N Dudley; W C Shyu; C H Nightingale; R Quintiliani
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

4.  Bioavailability of disopyramide in normal volunteers using unbound concentration.

Authors:  J Braun; F Sörgel; W P Gluth; S Oie
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

5.  High-pressure liquid chromatographic analysis of BMY-28142 in plasma and urine.

Authors:  R H Barbhaiya; S T Forgue; W C Shyu; E A Papp; K A Pittman
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

Review 6.  Clinical pharmacokinetics of antibiotics in patients with impaired renal function.

Authors:  W L St Peter; K A Redic-Kill; C E Halstenson
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447

Review 7.  Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions.

Authors:  R J Bertz; G R Granneman
Journal:  Clin Pharmacokinet       Date:  1997-03       Impact factor: 6.447

8.  Pharmacokinetics of sulfisoxazole in renal transplant patients.

Authors:  M Shermantine; J Gambertoglio; W Amend; F Vincenti; S Oie
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191

9.  Binding and disposition of sulfisoxazole in alcoholic cirrhosis.

Authors:  J P Cello; S Oie
Journal:  J Pharmacokinet Biopharm       Date:  1985-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.